Flow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: Results from 12 months of randomized treatment with topical cyclosporin A

Advances in Experimental Medicine and Biology

Volumn 506 B, Issue , 2002, Pages 761-769

  Baudouin, Christophe ^b   Brignole, Francois ^a   Pisella, Pierre Jean ^b   De Saint Jean, Magda ^b   Goguel, Alain ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CYCLOSPORIN A; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; REFRESH;

ADULT; AGED; AUTOIMMUNITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRY EYE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; KERATOCONJUNCTIVITIS SICCA; LACRIMATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0345700814     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0717-8_107     Document Type: Conference Paper

References (27)

1. C. Baudouin, N. Haouat, F. Brignole, J. Bayle, and P. Gastaud, Immunological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol. 76:545 (1992).
2. C. Baudouin, F. Brignole, F. Becquet, P.J. Pisella, and A. Goguel. Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci. 8:1458 (1997).
3. K.B. Bjerrum. Keratoconjunctivitis sicca and primary Sjøgren's syndrome in a Danish population aged 30-60 years. Acta Ophthalmol Scand. 75:281 (1997).
4. F. Brignole, M. De Saint Jean, M. Goldschild, F. Becquet, A. Goguel, and C. Baudouin. Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium: positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp Eye Res. 67:687 (1998).
5. F. Brignole, P.J. Pisella, M. Goldschild, M. De Saint Jean, A. Goguel, and C. Baudouin, C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 41:1356 (2000).
6. F. Brignole, P.J. Pisella, M. De Saint Jean, M. Goldschild, A. Goguel, and C. Baudouin. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci. 42:90 (2001).
7. M. De Saint Jean, F. Brignole, G. Feldman, A. Goguel, and C. Baudouin. Interferon gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells. Invest Ophthalmol Vis Sci. 40:2199 (1999).
8. N. Haneji, T. Nakamura, K. Takio, K. Yanagi, H. Higashiyama, I. Saito, S. Noji, H. Sugino, and Y. Hayashi. Identification of α-fodrin a as a candidate autoantigen in primary Sjøgren's syndrome. Science. 276:604 (1997).
9. T. Hikichi, A. Yoshida, Y. Fukui, T. Hamano, M. Ri, K. Araki, K. Horimoto, E. Takamura, K. Kitagawa, M. Oyama, et al. Prevalence of dry eye in Japanese eye centers. Graefe Arch Clin Exp Ophthalmol. 233:555 (1995).
10. M. Iwata, A. Kiritoshi, M.I. Roat, A. Yagihashi, and R.A. Thoft. Regulation of HLA class II antigen expression on cultured corneal epithelium by interferon gamma. Invest Ophthalmol Vis Sci. 33:2714 (1992).
11. D.T. Jones, D. Monroy, Z. Ji, S.S. Atherton, and S.C. Pflugfelder. Sjøgren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthlmol Vis Sci. 35:3493 (1994).
12. D.T. Jones, D. Monroy, Z. Ji, and S.C. Pflugfelder. Alterations of ocular surface gene expression in Sjøgren's syndrome. Adv Exp Med Biol. 438:533 (1998).
13. K.S. Kunert, A.S. Tisdale, M.E. Stern, J.A. Smith, and I.K. Gipson. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 118:1489 (2000).
14. A.K. Mircheff, J.P. Gierow, and R.L. Wood. Traffic of major histocompatibility complex class II molecules in rabbit lacrimal gland acinar cells. Invest Ophthalmol Vis Sci. 35:3943 (1994).
15. S.C. Pflugfelder, A.J. Huang, W. Feuer, P.T. Chuchovski, I.C. Pereira, and S.C. Tseng. Conjunctival cytologic features of primary Sjøgren's syndrome. Ophthalmology. 97:985 (1990).
16. S.C. Pflugfelder, D. Jones, Z. Ji, A. Afonso, and D. Monroy. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjøgren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 19:201 (1999).
17. P.J.M. Philip, C. Sartiaux, and the GEIL. Standardized multicentric quantimetry of differentiation antigens expression. The GEIL's approach in acute lymphoblastic leukemia. Leukemia Lymphoma. 13:45 (1994).
18. P.J. Pisella, F. Brignole, C. Debbasch, P.A. Lozato, C. Creuzot-Garcher, J. Bara, P. Saiag, J.M. Warnet, and C. Baudouin. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology. 107:1841 (2000).
19. K. Sall, O.D. Stevenson, T.K. Mundorf, B.L. Reis, and the CsA Phase 3 Study Group. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 107:631 (2000).
20. O.D. Schein, B. Munoz, J.M. Tielsch, K. Bandeen-Roche, S. West. Prevalence of dry eye among the elderly. Am J Ophthalmol. 124:723 (1997).
21. J.A. Smith M.E. Stern, J. Gao, T.A. Schwalb D.C. Rupp, and S.M. Whitcup. Conjunctival inflammation in non-Sjøgren's syndrome and Sjøgren's syndrome keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 41:S276 (2000).
22. M.E. Stern, R.W. Beurman, R.I. Fox, J. Gao, A.K. Mircheff, and S.C. Pflugfelder. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 17:584 (1998).
23. D. Stevenson, J. Tauber, and B.L. Reiss, B. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology. 107:967 (2000).
24. J. Tauber. A dose-ranging clinical trial to assess the safety and efficacy of cyclosporine ophthalmic emulsion in patients with keratoconjunctivitis sicca. Adv Exp Med Biol. 438:969 (1998).
25. K. Tsubota, T. Fujihara, K. Saito, and T. Takeuchi. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica. 213:16 (1999a).
26. K. Tsubota, K. Fukagawa, T. Fujihara, S. Shimmura, I. Saito, K. Saito, and T. Takeuchi. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci. 40:28 (1999b).
27. K. Turner, S.C. Pflugfelder, Z. Ji, W.J. Feuer, M.E. Stern, and B.L. Reis. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic solution. Cornea. 19:492 (2000).